News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Sotrovimab reduces hospitalization, death in patients with COVID-19 regardless of serostatus
23 Mar 2022
byElaine Soliven
Treatment with sotrovimab reduces the risk of all-cause hospitalization or death in patients with COVID-19 who are at high risk of progression to severe disease, regardless of anti-SARS-CoV-2 serostatus, according to a study presented at CROI 2022.
23 Mar 2022







